Search

Alan Schmalstig (University of North Carolina at Chapel Hill) and colleagues published a new paper on phage infection and killing of intracellular Mycobacterium abscessus.

Asher Leeks (Yale University) and colleagues explore open questions in the social lives of viruses in a recent invited review, including cooperation, conflict, and their impact on the population dynamics, evolutionary trajectory, and clinic

Kishen Patel and Kimberley Seed (University of California, Berkeley) published a new preprint on how a sporadic phage defense in epidemic Vibrio cholerae (mediated by the toxin-antitoxin system DarTG) is countered by a phage-encoded antitox

Ann Gregory, PhD via Twitter: Does anyone have any advice for where to purchase start-up equipment with a tight budget? (1) Class II Biosafety Cabinet, (2) Benchtop Microcentrifuge, (3) Anaerobic Chamber, (4) Autoclavable Micropipettes sets

This week Phagecast podcast published a new episode featuring an interview with Jean-Paul Pirnay! Dive into the world of phage therapy in Belgium – how it started, current practices, and future perspectives. This episode is the first of a t

Han Altae-Tran (Howard Hughes Medical Institute) and colleagues discovered over 200 new CRISPR-associated systems, including Cas14, an enzyme that cuts RNA precisely.

In a new review Alicia Fajardo-Lubian and Carola Venturini (Westmead Institute for Medical Research) explore phage potential to target intracellular pathogens. They summarize molecular evidence of phage internalization, proof of phage activ

Koen Wortelboer (University of Amsterdam) and colleagues conducted a controlled clinical trial to assess efficacy and safety of sterile fecal filtrate transplantation (FFT) in individuals with metabolic syndrome. Glucose metabolism was simi

Shinwon Lee (Pusan National University Hospital, Korea) and colleagues conducted a survey revealing that Korean infectious disease specialists are receptive to phage therapy.

L'Oréal has acquired Danish probiotic and microbiome research company Lactobio.

University of Arizona researchers, with a co-author from Reckitt (Lysol and Dettol), flushed household and public toilets seeded with bacteriophage MS2, a surrogate for human enteric viruses. Contamination of restroom surfaces did not depen

The Nobrega lab at the University of Southampton has launched phagecollection.org, the home of their new initiative to unite citizen scientists searching for phages to combat bacterial infections. They aim to educate the public about AMR an

Phage researchers from Belgium, the Netherlands, Germany, and Poland recently gathered at the 2nd BSVoM hands-on workshop on personalized phage therapy, organized by Jean-Paul Pirnay, Maya Merabishvili, and Tea Glonti and held at the Queen

Yves Briers will head up Obulytix, a new company based on the phage lysin-based platform leveraging AI to tackle bacterial infections he co-developed at Ghent University and KU Leuven. Obulytix has already attracted $4 M Euro investment fro

Eligo Bioscience has raised $30 million to advance and test their CRISPR-based medicine for acne vulgaris and develop their platform for other diseases. Congrats Eligo!

Phages in space!! Phil Huss (University of Wisconsin-Madison) and colleagues discovered that phage-host interactions in microgravity onboard the International Space Station have unique dynamics. They saw significant differences in mutationa

Ana Georgina Cobián Güemes (University of California San Diego) and colleagues discovered that jumbo phages are effective against extensively drug-resistant (XDR) Pseudomonas aeruginosa infections in contaminated preservative-free eyedrops.

Abdulkerim Karaynir (Recombinant DNA and Recombinant Protein Center, Turkey) and colleagues have demonstrated the successful transformation of environmental DNA into an active phage in E. coli.

Researchers at the University of California, Berkeley developed a CRISPR interference method to map gene essentiality in phages and applied it to the coliphages λ and P1, largely recapitulating the known essential genes of λ and giving new

Researchers at KIST Europe genetically modified filamentous fd phages to display shortened versions of a Cu(II)-specific peptide (HGFANVA). ICP-MS analyses showed improved Cu(II) binding by the engineered phages compared with wild-type fd,